Zotefoams PLC (LON:ZTF) Shareholders Are Liking The News That Peel Hunt Has Reiterated Their Hold Rating on the Stock

May 16, 2018 - By James Guidry

Zotefoams plc (LON:ZTF) Logo

Zotefoams PLC (LON:ZTF) Rating Reaffirmed

The rating of Zotefoams PLC (LON:ZTF) shares were restate by investment analysts at Peel Hunt. This was released in an analyst note on Wednesday morning.

Zotefoams plc (LON:ZTF) Ratings Coverage

Among 2 analysts covering Zotefoams (LON:ZTF), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Zotefoams has GBX 575 highest and GBX 570 lowest target. GBX 572.50’s average target is 4.66% above currents GBX 547 stock price. Zotefoams had 3 analyst reports since March 14, 2018 according to SRatingsIntel. The stock has “Hold” rating by Peel Hunt on Wednesday, May 16. The stock has “Add” rating by Peel Hunt on Monday, April 9. Canaccord Genuity maintained the shares of ZTF in report on Wednesday, March 14 with “Buy” rating.

The stock increased 2.24% or GBX 12 during the last trading session, reaching GBX 547. About 41,810 shares traded. Zotefoams plc (LON:ZTF) has 0.00% since May 16, 2017 and is . It has underperformed by 11.55% the S&P500.

Zotefoams plc, together with its subsidiaries, makes, distributes, and sells polymer foam in the United Kingdom and Eire, Continental Europe, North America, and internationally. The company has market cap of 240.09 million GBP. The firm operates through Polyolefins, High-Performance Products , and MuCell Extrusion LLC (MEL) divisions. It has a 40.52 P/E ratio. It offers AZOTE family of polyolefin foams under the Plastazote, Evazote, and Supazote brands; ZOTEK range of high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK F, ZOTEK N, and ZOTEK PEBA brand names.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: